End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
2014 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Managers | Title | Age | Since |
---|---|---|---|
Karen Rogers
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - | |
Corporate Officer/Principal | - | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 06-08-31 | |
Director/Board Member | 70 | 13-09-24 |
1st Jan change | Capi. | |
---|---|---|
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+56.46% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+5.39% | 8.31B |
- Stock Market
- Equities
- Stock